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enzymes, COX-1, COX-2, cPGES and mPGES was demon-
strated in OA cartilage by positive immunostaining. IL-1 sig-
niﬁcantly augmented expression of COX-2 and mPGES in OA
cartilage. Treatment of OA cartilage/chondrocytes with PGE2
(0.1-10uM) resulted in the following dose dependent catabolic
effects with respect to aggrecan metabolism 1) inhibition of pro-
teoglycan synthesis (35S incorporation) by chondrocyte cultures
to levels of 75% of control (p<0.01), 2) augmentation of release
of aggrecan fragment CS846 epitope, 3) inhibition of aggrecan
gene expression and 4) induction of production of pro-MMP-13,
IL-6 and IL-8. The potency of PGE2 effects on PG synthesis
were comparable to that of IL-1b, and the inhibitory effects of
the combination of IL-1 and PGE2 (10uM) were additive. PGE2
augmentation of collagen degradation (C12C assay) could be
blocked by MMP inhibitor, Ilomastat (5uM) (p<0.05) in OA car-
tilage explant cultures. In OA chondrocytes, PGE2 inhibition by
celecoxib (2uM) treatment partially reversed IL-1 mediated in-
hibition of PG synthesis from 45% to 65% of control values
(p<0.01). Similarly, IL-1 mediated induction of aggrecanase 4
and 5 (ADAMTS) was also reversed by celecoxib treatment by
more than 60%. Interestingly, blocking of EP4 receptor, a known
receptor of PGE2, with EP4 antagonist (A23858) mimicked cele-
coxib, and inhibited ADAMTS 4 and 5 expressions as analyzed
by real time PCR.
Conclusions: Our results suggest that IL-1 mediated inhibition
of proteoglycan aggrecan expression and enhanced degradation
is, in part, mediated by prostaglandin E2 acting via the EP4
receptor.These ﬁndings underscore the importance of PGE2 as
a central mediator of OA pathogenesis.
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ANTI-CATABOLIC EFFECT OF FIBROBLAST GROWTH
FACTOR-2 IN HUMAN ARTICULAR CARTILAGE
Y. Sawaji, J. Saklatvala
Imperial College, London, United Kingdom
Purpose: Articular chondrocytes are surrounded by an extra-
cellular pool of ﬁbroblast growth factor (FGF)-2. The roles of
FGF-2 on aggrecan catabolism by aggrecanases; a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTS)-4
and -5 were investigated in human articular cartilage.
Methods: Normal human articular cartilages were stimulated
with IL-1α in the presence or absence of FGF-2. Aggrecan
catabolism was assessed by measuring the release of gly-
cosaminoglycan by DMMB and assayed by western blotting
with neo-epitope antibodies (ARGS and AGEG) which recog-
nize aggrecanase dependent aggrecan fragments. The expres-
sion of ADAMTS-4 and -5 were measured by RT-PCR. Matrix
metalloproteinase (MMP)-1, -3 and -13 and tissue inhibitor of
metalloproteinases (TIMP)-1 and 3 production was measured
by western blotting. Interleukin (IL)-6 and -8 were measured by
ELISA. Proteoglycan synthesis was monitored by incorporation
of 35S labelled sulphate incorporation.
Results: IL-1α caused cleavage of aggrecan in cultured human
articular cartilage explants, with release of aggrecan fragments
containing ARGS and AGEG neo-epitopes. These were inhibited
by exogenous FGF-2 (1-100 ng/ml). TNFα and retinoic acid also
stimulated release of neo-epitope bearing fragments and this was
also suppressed by FGF-2. IL-1α induced mRNA for ADAMTS-4
and ADAMTS-5 in cartilage explants and isolated chondrocytes.
FGF-2 inhibited the IL-1α-induced increase in both ADAMTS-
4 and ADAMTS-5 mRNA. IL-1α-induced aggrecan degradation
was inhibited by exogenous TIMP-1 as well as N-terminal TIMP-
3, although FGF-2 did not affect their production when IL-1α was
present. FGF-2 did not prevent IL-1α suppression of proteoglycan
synthesis nor its ability to stimulate the production of IL-6, -8,
MMP-1, -3 and -13.
Conclusions: Our ﬁndings suggest that FGF-2 may play a
chondroprotective role in human articular cartilage by controlling
the expression of the aggrecanase, ADAMTS-4 and ADAMTS-5.
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ACTIVATION OF p38α AND p38γ BY IL-1 AND INHIBITION
BY IGF-I AND OP-1
D. Long, R.F. Loeser Jr.
Wake Forest Universtiy, Winston Salem, NC
Purpose: IGF-I and OP-1 have been shown to inhibit IL-1β stim-
ulation of chondrocyte MMP expression. IL-1 signaling requires
activation of the p38 MAP kinase. Four different isoforms of p38
have been previously described (alpha, beta, gamma, and delta)
but their function has not been deﬁned in chondrocytes. The
aim of this study was to determine which p38 isoforms mediate
chondrocyte IL-1 signaling and determine if they are inhibited by
the growth factor combination of IGF-I and OP-1.
Methods: Human articular chondrocytes were isolated by enzy-
matic digestion of normal cartilage obtained from tissue donors
and OA cartilage removed during joint replacement. Cells were
cultured in DMEM/F12 with 10% serum to conﬂuency and them
made serum-free for stimulation studies. Speciﬁc p38 isoform
expression was detected by Western blotting of protein lysates
using p38 isoform speciﬁc antibodies and RT-PCR of RNA prepa-
rations using p38 isoform speciﬁc primers. Cytosol and nuclear
preparations were made using a commercially available kit to
detect p38 translocation to the nucleus after cytokine stimulation.
Results: RT-PCR and Western blotting showed that p38α and
p38γ were the most highly expressed p38 isoforms in chondro-
cytes. Western Blotting using a phospho-speciﬁc p38 antibody
(that recognizes all four p38 isoforms) after IL-1 stimulation
of chondrocytes revealed the presence of two bands. Based
on molecular weight and previous studies, we conﬁrmed that
one band was p38α. We used 2-D gel electrophoresis to also
conﬁrm that IL-1 stimulated phosphorylation of p38γ. Translo-
cation experiments revealed a shift of phosphorylated p38 to
the nucleus after IL-1 stimulation. This phosphorylated p38 was
determined to be p38α, as this isoform was shown to be present
in the nucleus whereas p38γ could not be detected in the nu-
clear preparations. The combination of IGF-1 and OP-1, added
30 minutes prior to IL-1 stimulation, inhibited IL-1 induced p38
phosphorylation as well as IL-1 induced phosphorylation of ATF-
2 and MAPKAPK-2, two signaling molecules directly downstream
of p38α but not p38γ.
Conclusions: These results are, to our knowledge, the ﬁrst
to demonstrate IL-1 phosphorylation of two p38 isoforms (al-
pha and gamma) in chondrocytes. Although phosphorylation of
both isoforms was stimulated by IL-1 and phosphorylation of
p38α was inhibited by IGF-I+OP-1, it appeared that p38α me-
diates its effects at the level of gene transcription. p38α but
not p38γ was found to translocate to the nucleus and the p38α
substrates ATF-2 and MAPKAPK-2 were both phosphorylated.
Further experiments are needed to determine the role of p38γ in
chondrocyte signaling.
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JNK2 SULFENIC ACID FORMATION IN THE REDOX
REGULATION OF α5β1 INTEGRIN SIGNALING
E.A. Erickson, C.M. Furdui, A.W. Tsang, J.S. Fetrow,
L.B. Poole, R.F. Loeser
Wake Forest University, Winston Salem, NC
Purpose: Reactive oxygen species (ROS) act as secondary
messengers in signaling cascades activated in response to extra-
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cellular stimuli. ROS oxidation of speciﬁc cysteine (cys) residues
within signaling proteins, resulting in the formation of cys sulfenic
acids, is a common mechanism in various redox-sensitive sig-
naling pathways. In determining the role of ROS in cartilage
degradation, we have previously shown the 110kD ﬁbronectin
fragment (FN-f) stimulated α5β1 integrin requires ROS for the
activation of its signaling pathway and downstream MMP-13 ex-
pression. Furthermore, we have preliminary evidence that cys
sulfenic acid formation is required for FN-f stimulated MMP-13
expression in chondrocytes and that JNK2 is a candidate for
forming cys sulfenic acid in response to FN-f. The objective
of the current study was to identify the sulfenic acid-forming
cysteine residue(s) of JNK2.
Methods: An analytical method called active site proﬁling was
used to determine whether any of the 10 cys residues within
JNK2 were likely candidates for redox regulation. Active site
proﬁles for each of the cys residues in JNK2 were made us-
ing known redox regulated proteins, including peroxiredoxin and
glutaredoxin. To identify the speciﬁc cys residue forming cys
sulfenic acid, a reagent called DCP-biotin, which reacts speciﬁ-
cally and irreversibly with sulfenic acids, was used to label any
oxidized cysteines within JNK2 for identiﬁcation by mass spec-
trometry. After an incubation with DCP-biotin and 2µM H2O2,
puriﬁed recombinant JNK2 was subjected to SDS-PAGE elec-
trophoresis and digested in-gel with trypsin. The JNK2 tryptic
peptides were then analyzed by nanoLC-MS/MS on a Thermo
LTQ mass spectrometer. To investigate whether the formation of
the JNK2 sulfenic acid might result in disulﬁde bond formation
and dimerization, puriﬁed recombinant JNK2 was incubated with
DCP-biotin alone, with 2µM H2O2, or with 20µM H2O2, and run
on a non-reducing gel for immunoblotting with total JNK Ab and
streptavidin-HRP.
Results: The active site proﬁling method identiﬁed Cys79 and
Cys222 in JNK2 as potential sites for redox regulation. Mass
spectrometry analysis of JNK2 treated with H2O2 and DCP-biotin
identiﬁed Cys222 as the only cys labeled with DCP-biotin. Unlike
the other 9 cysteine residues, the mass of Cys222 was increased
by 395.5 (the mass of DCP-biotin) indicating the presence of a
sulfenic acid. When JNK2 was run on a non-reducing gel, higher
molecular weight bands were observed at 110kD, suggesting
JNK2 dimers may form through disulﬁde bonds after sulfenic
acid formation.
Conclusions: These results have demonstrated for the ﬁrst time
that increased levels of ROS lead to the direct oxidation of JNK2
at Cys222 to form a sulfenic acid. This implicates that JNK2
acts as a redox-sensitive signaling mediator for the α5β1 inte-
grin pathway and thereby contributes to the ROS regulation of
chondrocyte MMP-13 production. Further investigation of JNK2
and other redox-sensitive signaling intermediates which regulate
MMP production could aid in the identiﬁcation of potential ther-
apeutic targets that can slow or stop cartilage degradation in
arthritis patients.
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THE EFFECT OF NEUROPEPTIDES ON BOVINE
ARTICULAR CHONDROCYTE PROLIFERATION
J. White, A. Herzog, E. Bergersen, J. Snitzer, J. Decker,
R. Vanderby, H. Stampﬂi, L.D. Kaplan
University of Wisconsin School of Medicine and Public Health,
Madison, WI
Purpose: Damage to articular cartilage leads to an incomplete
healing response. This has elicited interest in improving the un-
derstanding of chondrocyte biology and ﬁnding ways to stimulate
a more effective repair response. Neuropeptides play a role in
the proliferative and reparative processes of many tissue types,
but little is known about their effects on articular cartilage. This
study aims to investigate the effect of four neuropeptides on
articular chondrocytes.
Methods: Bovine chondrocytes were cultivated in monolayer
culture in media alone or media containing one of four neu-
ropeptides: neuropeptide Y (NPY), calcitonin gene-related pep-
tide (CGRP), substance P (SP), or vasoactive intestinal peptide
(VIP). Available cartilage from the articular surface of the femoral
trochlea, femoral condyles, and patella of freshly slaughtered
veal (n=8) was enzymatically digested overnight in Dulbeco’s
Modiﬁed Eagles Media (DMEM) containing 0.5 mg/mL of both
hyaluronidase and collagenase. These chondrocytes were then
plated at 1x10 5 cells/mL in DMEM complete media with 5%
FCS and Pen/Strep. Cells were plated using 100 uL of the cell
suspension in a 96 well tissue culture plate with 6 replicates for
proliferation analysis. After 24 hour incubation, media was ex-
changed with new DMEM complete media with the appropriate
treatment. The treatment groups consisted of a control (media
only), a positive control (media + 100 ng/mL IGF-1) and the
treatment group (media with neuropeptide). Treatments included
three concentrations of each neuropeptide. The SP concentra-
tions were 5, 50, and 500 ug/mL, the CGRP concentrations were
10, 100, and 1000 ng/mL, and the NPY concentrations were
0.05, 0.5, and 5 ug/mL. Finally, the VIP concentrations were 100,
1000, and 10,000 ng/mL. Media was exchanged every two days
with new DMEM plus treatment. The cultures were carried out
to day 8. Proliferation assays, assessed with the Promega Cell
Titer Glo luminescence assay, were run every two days. Analysis
was performed using a split-plot ANOVA and pairwise t-tests.
Results: Substance P showed a statistically signiﬁcant stimu-
latory effect on chondrocyte proliferation that was greatest at a
concentration of 5 µg/ml (see ﬁgure 1). VIP and NPY showed a
Figure 1. Effect of SP on Articular Chondrocyte Proliferation. SP showed a stim-
ulatory effect on proliferation on all days.
Figure 2. Effect of VIP on Articular Chondrocyte Proliferation. VIP showed a
dose dependent suppressive effect on proliferation.
